ObjectiveThe aims of our study was to investigate the protective effects andmechanism of lipopolysaccharide (LPS)-induced cardiac hypertrophy byastragalus polysaccharide (APS).Methods1-2d in vitro cultured neonatal SD rats neonatal rat cardiac myocytes after48h, Myocardial cells of neonatal rats were cultured in vitro and were dividedinto normal control groups, LPS1mg·L-1model group, LPS+APS5,15,45mg·L-1group, LPS+VER1μmol·L-1group.The total protein was measured by theBradford Protein Assay Kit, The size was assayed by computer photograanalysis; ANP mRNA expression was measured by RT-PCR;tumor necrosisfactor (TNF-α) levels was determined by enzyme-linked immunosorbent assay(ELISA);The cell viability was assessed by MTT assayusing;Fluo-3/Amfluorescent dye load cell, the laser confocal microscope measured theconcentration of intracellular calcium transient.ResultsCompared with normal control group,LPS1mg·L-1significantly increasedthe total protein content and size of cardiomyocytes, ANP mRNA expressionwas significantly increased,the release of TNF-α protein was significantly increased,the cell viability was decreased(P<0.01)and intracellular [Ca2+]itransient peak increase. Compared with the LPS model group, pre-accession5,15,45mg·L-1of APS can inhibit myocardial cell volume and total proteincontent increases, ANP mRNA expression decreased in varying degrees,whilecells of TNF-α were significantly reduced,and the cell viability increases(P<0.05), in which APS15,45mg·L-1group can be restored to normal levels ofthe control group(P>0.05), APS15mg/L LPS can antagonize the normalintracellular [Ca2+]itransient amplitude increased role.ConclusionsAPS do has a good protective effect of cultured cardiac myocytes and itsmechanism may be related to decreased release of TNF-α and inhibiting[Ca2+]i. |